Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8783168 | Medicina Reproductiva y Embriología Clínica | 2016 | 9 Pages |
Abstract
Oocyte vitrification in public health systems should have some cost-benefit conditions. It should be offered in cases with a real risk of ovarian reserve loss, but when there are adequate conditions to achieve an ovarian stimulation response to be able to obtain a sufficient number of oocytes. Patients with endometriosis will be candidates for vitrification if they fulfil two conditions: 1) bilateral endometrioma of more than 4 cm, or post-surgical recurrence of endometriosis, and 2)- age â¤Â 35 years and ovarian reserve markers excluding low ovarian reserve (AMH > 1 ng/ml; antral follicle count > 5; FSH > 10 mg/ml). As 10 vitrified oocytes should be considered a sufficient number, a maximum of 2 cycles will be offered to reach this number. Follow-up of these cases will allow an evaluation of the efficacy and efficiency of this policy to be made in the future.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Laura de la Fuente, SofÃa Ortega, Ana Monzó, Berta MartÃn, Maria José Iñarra, Corazón Hernández, Belén Castells, Bárbara Romero, Jose Luis Muñoz, Ana Belen Casas,